References

10.1201/9781003508601-8

10.1201/9781003508601-8 · External reference

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

10.1016/s0140-6736(21)00306-8 · 2021 · External reference

Cellular uptake of nanoparticles: journey inside the cell

10.1039/c6cs00636a · 2017 · External reference

Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs

10.1016/j.dmpk.2021.100424 · 2021 · External reference

Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a case study

10.1021/ie2006752 · 2011 · External reference

The hitchhiker’s guide to flow chemistry∥

10.1021/acs.chemrev.7b00183 · 2017 · External reference

Continuous flow synthesis: a promising platform for the future of nanoparticle-based drug delivery

2024 · External reference

Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device

10.1021/acs.nanolett.1c01353 · 2021 · External reference

Flow chemistry: recent developments in the synthesis of pharmaceutical products

10.1021/acs.oprd.5b00325 · 2016 · External reference

How to approach flow chemistry

10.1039/c9cs00832b · 2020 · External reference

Microfluidic vortex focusing for high throughput synthesis of size-tunable liposomes

10.1038/s41467-022-34750-3 · 2022 · External reference

Synthesizing lipid nanoparticles by turbulent flow in confined impinging jet mixers

2024 · External reference

Three-dimensional-printed vortex tube reactor for continuous flow synthesis of polyglycolic acid nanoparticles with high productivity

10.3390/nano13192679 · 2023 · External reference

Key fabrications of chitosan nanoparticles for effective drug delivery using flow chemistry reactors

10.2147/ijn.s433756 · 2023 · External reference

Optimization of lipid-based nanoparticles formulation loaded with biological product using a novel design vortex tube reactor via flow chemistry

10.2147/ijn.s474775 · 2024 · External reference

Development and evaluation of drug-loaded niosomes fabricated by flow chemistry: a novel vortex tube reactor approach

10.1016/j.onano.2025.100243 · 2025 · External reference

A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient

10.1038/s41598-024-52685-1 · 2024 · External reference

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability

10.1016/j.ijpharm.2021.120586 · 2021 · External reference

Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization

2017 · External reference

Quantification of objective concentrations of DNA impurities in mRNA vaccines

10.1016/j.vaccine.2025.127022 · 2025 · External reference

Conjugation of mannans to enhance the potency of liposome nanoparticles for the delivery of RNA vaccines

10.3390/pharmaceutics13020240 · 2021 · External reference

Continuous-flow production of liposomes with a millireactor under varying fluidic conditions

10.3390/pharmaceutics12111001 · 2020 · External reference

Microfluidic fabrication of monodispersed pharmaceutical colloidal spheres of atorvastatin calcium with tunable sizes

10.1021/ie901365w · 2010 · External reference

Precise control of liposome size using characteristic time depends on solvent type and membrane properties

10.1038/s41598-023-31895-z · 2023 · External reference

Manufacturing considerations for the development of lipid nanoparticles using microfluidics

10.3390/pharmaceutics12111095 · 2020 · External reference

Naturally derived membrane lipids impact nanoparticle-based messenger RNA delivery

10.1007/s12195-020-00619-y · 2020 · External reference

Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation

10.1021/ja301621z · 2012 · External reference

Simulating copolymeric nanoparticle assembly in the co-solvent method: how mixing rates control final particle sizes and morphologies

10.1016/j.polymer.2017.07.057 · 2017 · External reference

On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA

10.1021/acsnano.8b01516 · 2018 · External reference

Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA

10.1038/mtna.2012.28 · 2012 · External reference

Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines

10.1016/j.omtn.2019.01.013 · 2019 · External reference

Retention characteristics of sterile filters–effect of pore size and structure

10.1016/j.memsci.2021.119436 · 2021 · External reference

Process development of tangential flow filtration and sterile filtration for manufacturing of mRNA-lipid nanoparticles: a study on membrane performance and filtration modeling

10.1016/j.ijpharm.2025.125520 · 2025 · External reference

Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA

10.1016/j.jconrel.2016.05.059 · 2016 · External reference

The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer

10.1038/gt.2008.60 · 2008 · External reference

Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis

10.1042/bj20031253 · 2004 · External reference

Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis

10.1038/mt.2013.54 · 2013 · External reference

Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo

10.1016/j.ejpb.2024.114207 · 2024 · External reference

Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques–an evaluation of particle properties and efficiency

10.1016/j.onano.2023.100161 · 2023 · External reference